These experiments tested whether nucleus accumbens muscarinic or nicotinic acetylcholine receptor activation is required for rats to learn to lever press for sucrose. Muscarinic blockade with scopolamine (1 or 10 g/side), but not nicotinic antagonism with mecamylamine (10 g/side), inhibited learning and performance when applied to the core or shell. Further experiments showed that acute accumbens scopolamine treatment increased locomotor activity and reduced sucrose consumption. However, microanalyses of behavioral events in the instrumental chamber revealed that reductions of lever press performance during muscarinic blockade were not due to gross motor dysfunction. Accumbens core scopolamine was subsequently shown to reduce the amount of work rats would expend under a progressive-ratio paradigm. These novel results implicate nucleus accumbens muscarinic receptors in the modulation of appetitive learning, performance, and motivation for food.
Nucleus accumbens acetylcholine regulates appetitive learning and motivation for food via activation of muscarinic receptors
The nucleus accumbens is generally believed to be an important substrate for reward and motivational processes, and is critical for the acquisition of multiple forms of appetitive behaviors, reinforced by natural or drug rewards (e.g., Kelley, 1999; Koob, 1992) . It receives direct glutamatergic projections from cortical regions important for learning and memory processes (e.g., McGeorge & Faull, 1989) , as well as dopaminergic inputs from the tegmentum argued to convey predictive reward information (Schultz, 1998) . The medium spiny output neurons of the nucleus accumbens subsequently project to ventral pallidum and the substantia nigra (e.g., Heimer, Zahm, Churchill, Kalivas, & Wohltmann, 1991; Nauta & Domesick, 1984) , regions that subsequently modulate motor output. Pharmacological blockade of either glutamatergic or dopaminergic receptors within the nucleus accumbens has been shown to impair appetitive learning (Kelley, Smith-Roe, & Holahan, 1997; Smith-Roe & Kelley, 2000) .
Recently, intrinsic cholinergic interneurons have also been implicated in mechanisms of striatal plasticity. Although these large aspiny interneurons comprise only about 5% of the striatum's neuronal population (Graveland & DiFiglia, 1985) , they are its primary source of acetylcholine. Cholinergic modulation of striatum-based neural and behavioral plasticity is supported by converging evidence from both in vitro and in vivo experiments that has shown influences of muscarinic and nicotinic blockade on cellular plasticity and behavior (Calabresi, Centonze, Gubellini, Pisani, & Bernardi, 1998; Partridge, Apparsundaram, Gerhardt, Ronesi, & Lovinger, 2002) . Early behavioral studies demonstrated that dorsal striatal cholinergic mechanisms are involved in learning of both leverpressing and active avoidance paradigms (for review see Prado-Alcala, 1985) . Additionally, selective lesions of striatal cholinergic neurons in mice have been shown to impair rewardrelated learning (Kitabatake, Hikida, Watanabe, Pastan, & Nakanishi, 2003) . Tonically active neurons in monkeys, that are argued to be cholinergic based on similar firing patterns to morphologically identified neurons in vitro, show flexible alterations in firing rate at the presentation of primary reward or aversive stimuli (e.g., Matsumoto, Minamimoto, Graybiel, & Kimura, 2001; Ravel, Legallet, & Apicella, 2003; Sardo, Ravel, Legallet, & Apicella, 2000) .
Thus, the cholinergic interneurons of the striatum are capable of dynamic changes in relation to salient environmental stimuli.
Despite the known role of the nucleus accumbens in appetitive learning paradigms, to our knowledge no study has systematically examined the influence of intra-accumbens cholinergic blockade on behavioral plasticity. These experiments explored the effects of muscarinic and nicotinic antagonism within the rat nucleus accumbens upon instrumental learning in a leverpress task for sucrose reward. We report that muscarinic blockade of either nucleus accumbens core or shell, but not nicotinic receptor antagonism, attenuates instrumental learning and performance. Additional experiments examined acute locomotor and feeding effects of drug treatment, as well as its impact on how hard rats would work to obtain sucrose under a progressive ratio schedule. Together, the results from these experiments suggest a possible role for nucleus accumbens cholinergic activation in mediating the motivational salience of sucrose reward.
Method

Subjects and Housing
A total of 109 Male Sprague-Dawley rats (Harlan, Madison, WI) were dually housed in clear plastic cages. The colony room was maintained at ~21 C on a 12:12 light-dark cycle (lights on at 7 am). Following 2 days acclimation to the laboratory, rats were handled daily for a minimum of one week prior to surgeries. During this time, standard rat chow and water was available ad libitum. All procedures and animal care were performed in accordance with NIH guidelines for the ethical use of animals in research.
Surgery
Rats were anesthetized with a Ketamine-Xylazine cocktail (100 mg/kg-10mg/kg).
Standard aseptic procedures were utilized to implant indwelling stainless steel guide cannula (23 gauge) bilaterally above the nucleus accumbens core (flat skull; 1.3 mm anterior and 1.7 mm lateral to bregma, 5.3 mm ventral to skull surface) or shell (tooth bar 5 mm above interaural zero; 3.1 mm anterior and 1 mm lateral to bregma, 5.3 mm ventral to skull surface). Guide cannula were affixed to the skull with the use of screws and dental acrylic. Rats recovered for at least 7 days prior to food restriction and behavioral testing.
Drugs and Microinfusions
The competitive muscarinic acetylcholine receptor antagonist scopolamine methyl bromide and the noncompetitive nicotinic acetylcholine receptor antagonist mecamylamine (purchased from Sigma, St. Louis, MO) were dissolved in saline for these experiments. Drug solutions were mixed at the beginning of each experiment, and stored in 60 l aliquots at 4 C until used.
For all experiments, rats were habituated to injection procedures for three days prior to experimental infusion. Each rat received two mock injections (during which injection cannula were lowered only to the bottom of the guide cannulae and the infusion pump was activated without solutions present) and one saline injection. For saline and drug infusions, microinfusion cannula (30 gauge) were lowered to the desired target site (2.5 mm below the bottom of the 10 mm guide cannula). These cannula were connected to a syringe via polyethylene tubing, and 0.5 l of solution was delivered (at a rate of .32 l per min) by a Harvard Apparatus (Holliston, MA) microinfusion pump (infusion time = 1.33 min). Rats were gently restrained by the experimenter during the infusions. Following one min diffusion time, the injection cannula were removed and the wire stylets replaced. Rats were returned to their home cage for approximately five min, after which they were transferred to the testing apparatus. Individual rats received no more than seven infusion sessions, each separated by at least 24 hr.
Instrumental shaping procedure
Following recovery from surgery, food was restricted to allow for gradual reduction of body weight to 85% of free-feeding levels. During food restriction, rats were given four grams of sucrose (45 mg pellets, BioServ, Frenchtown, NJ) with their daily chow to prevent neophobia during testing.
Rats were trained in commercially constructed instrumental chambers (Coulbourn Instruments, Allentown, PA), equipped with two retractable levers, a house light, a row of stimulus lights, and a food tray into which 45 mg sucrose pellets could be dispensed. The chambers interfaced with a computer that recorded the time of each experimental event and controlled all reinforcement contingencies. Rats were habituated to the chamber during the three days of mock and saline injections noted above. Following the mock infusions, they were placed into the chamber for 15 min. During these sessions, sucrose pellets were randomly delivered to the food tray in intervals averaging 15 (RT-15", mock day 1) or 30 (RT-30", mock day 2 and saline infusion days) seconds, allowing the rats to associate the reward with delivery and the food tray.
Rats were assigned to one of four drug treatment groups for the duration of the experiment. In general, experimental groups comprised eight animals (actual numbers of all groups are given in Method). These treatment groups received the following, injected bilaterally in the volume of 0.5 l: 10 g mecamylamine, 10 g scopolamine, 1.0 g scopolamine, or saline vehicle. These amounts of drug were determined from previous reports demonstrating efficacy of these doses on behavioral assessments in other paradigms (e.g., Hildebrand, Panagis, Svensson, & Nomikos, 1999; Ragozzino, Jih, & Tzavos, 2002) .
On the first instrumental training session, rats were given the first drug treatment, and five minutes later placed into the operant chamber. The right lever was projected into the chamber and bar presses were reinforced on a FR1 (one sucrose pellet delivery per lever press) schedule of reinforcement. A conjoint RT-30" schedule was maintained for the first 2 instrumental training sessions (Drug Days 1 and 2) to encourage exploratory behaviors. On the third day of instrumental training (and continuing until the end of the experiment), the RT schedule was removed, and upon completion of the 50 th response in the session, the FR1 contingency was changed to an RR2 schedule of reinforcement (each response resulted in a reinforcer delivery at a probability of 0.5). This limited the effects of satiety sometimes seen with FR1 schedules, allowing for easier differentiation of treatment effects. All sessions were 15 min. Rats received drug treatments for the first 5 days of instrumental training, and a subsequent injection on either day 11 or 14, once all groups had achieved an asymptotic level of performance (see results). No infusions were given on intervening days. The primary dependent variables were lever presses and nose pokes into the feeding chamber across days.
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Examination of unconditioned drug effects on locomotion and feeding
Separate groups of rats were handled, operated upon, and food restricted in the same manner as for instrumental training. During mock infusion days, rats were taken to a novel room and placed into a plastic cage similar to their home cage. Full access was given to water and sucrose pellets during 15 min sessions. On drug treatment days, animals received a drug infusion five minutes prior to placement in the cage. Feeding duration, feeding bouts, latency to feed, total food intake, locomotion, rearing, and drinking was measured by an experimenter blind to drug conditions via a keypad connected to a computer. These were within-subjects experiments; each rat received each drug treatment across the course of several days. Infusions were separated by at least 24 h, and presentation of the drug treatments were randomized for each rat. Drugs and doses were identical to those used in the instrumental shaping paradigm.
Progressive ratio procedure
In this experiment, training preceded surgery. Following acclimation, handling, and food-deprivation, eight naïve rats were habituated to the operant chambers with 3 daily sessions of a RT-30" reinforcement schedule (with no lever present) for 30 min. On the subsequent and following days, the lever was inserted into the chamber, and training proceeded for three sessions each on FR1, FR3, and FR5 schedules of reinforcement, at which point all animals had achieved reliable responding on the lever. Rats were then switched to a progressive ratio 2 (PR-2) schedule of reinforcement for seven sessions. In this schedule, the rat was reinforced for the first lever press, and then was required to increase the number of responses by two lever presses for each subsequent pellet delivery. Thus, progressively more effort was required to earn each reinforcer. The number of responses required in the final completed ratio determined the break point, a well-validated measure reflecting the strength of the reinforcer and the motivational state Acetylcholine and appetitive behavior 9 of the animal (Arnold & Roberts, 1997; Hodos, 1961) . At the end of seven days with the PR-2 schedule, all animals had achieved high levels of lever responding. They were returned to ad lib feeding and underwent surgery to implant guide cannula above the nucleus accumbens core.
One week following surgery, the non-food deprived animals were returned to the chambers, and the session length for the PR-2 schedule was increased to 1 hr. Once the rats had achieved stable break points, they were habituated to the injection procedure (as above). Each rat subsequently received five treatments of scopolamine (at 0, 0.1, 1.0, 5.0 and 10 g/side in 0.5 l saline) five minutes prior to the experimental sessions. The order of the drug presentation was randomized for each animal, and drug treatments were separated by at least two days of additional PR-2 training to stabilize baseline performance. Dependent measures were total number of bar presses and the last completed reinforcement ratio (break point).
Statistical Analysis
Standard parametric statistics were applied to the data from these experiments. For the instrumental learning paradigm, mixed design analyses of variance (ANOVAs) were conducted with treatment as the between subjects factor and day of training as the within subjects factor.
Such ANOVAs were run for the entire training phase of the experiment to assess drug effects on learning (i.e., for most experiments, days 1-13). Significant results of the ANOVA (p < .05)
were followed up by analyses of simple main and interaction effects, run between each treatment group and the saline control group. A separate mixed-design ANOVA was run on the final two days of the experiment (i.e., the final day of training and the final drug test) to assess the effects of the drug on performance after the task was learned. Post-hoc comparisons of performance utilized the Tukey HSD statistic. A group of rats was considered to be reliably lever-pressing on the first day that the group's lower-bound 95% confidence interval exceeded zero.
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To follow up on learning and performance effects of scopolamine treatment on the instrumental learning paradigm, statistical analyses were supplemented by microstructural behavior analysis. Raw data files for the last two days of each experiment were exported from the Colbourn system into Excel®. Lever presses, nose pokes, and earned reinforcers that occurred during each session were time-stamped by Graphic State Notation. Latencies were calculated between three behavioral dyads: the time between each lever press and a nose poke, the time between the delivery of a sucrose reinforcer and the subsequent nose poke, and the time between a nose poke and the next bar press. The distribution of median latencies for each scopolamine treatment group was compared between the final instrumental training day and the subsequent drug test on performance. These microanalyses allowed a detailed assessment of ongoing behavior in the operant chamber.
Standard repeated-measures ANOVAs were utilized to examine the effects of drug on dependent measures in the locomotor and feeding control paradigm, as well as for the progressive ratio experiment. Post-hoc comparisons were made with the Tukey HSD for locomotion and food intake measures; planned contrasts were used to evaluate the effect of each drug dose on break point and lever pressing measures (vs. the saline control) within the progressive ratio experiment.
Histology
Once the experiments were complete, rats were deeply anesthetized with sodium pentobarbital and perfused through the heart with a 0.9% buffered NaCl solution, followed by 10% formalin. Brains were removed and allowed to sink in 10% sucrose formalin. Sixty micrometer frozen sections were then sliced through the penetrated area with a cryostat.
Sections were stained with cresyl violet. The tips of the cannula were confirmed by light Acetylcholine and appetitive behavior 11 microscopy, and charted in reference to (Paxinos & Watson, 1998) . Eight animals were excluded from additional analysis due to cannula misplacement. Representative photomicrographs of cannula placements, as well as the charted locations of nucleus accumbens core and shell placements for three experimental groups each, are shown in Figure 1 .
Results
Effects of scopolamine and mecamylamine infusions into nucleus accumbens core or shell on learning and performance of instrumental conditioning for sucrose reward
In general, intra-nucleus accumbens treatments with high (10 g/side) or low (1.0 g/side) doses of the muscarinic antagonist scopolamine impaired learning when infused into either shell or core (Fig. 2) . High doses of scopolamine also reduced performance on Day 14
following learning in both regions; the low dose impaired performance only in the nucleus accumbens shell. Infusions of the nicotinic receptor antagonist mecamylamine had no effect on learning or performance of the operant response. Similar systematic decreases were observed for nose poke frequencies during muscarinic blockade (data not shown). Statistical presentation of the bar press data for each experiment are detailed in subsequent sections for nucleus accumbens core and shell manipulations.
Nucleus accumbens core. Examination of drug effects in the nucleus accumbens core was comprised of two experiments; each tested scopolamine or mecamylamine treatment, respectively, against a concurrent saline control group. For scopolamine-treated animals, repeated measures ANOVA across days revealed significant effects for treatment group (F 2,19 = 4.62, p < .05), day of training (F 12,288 = 61.86, p < .001), and the treatment X day interaction (F 24,228 = 3.515, p < .001). As seen in Figure 2A , these effects were the result of a dosedependent learning impairment in the scopolamine groups during the initial five days of drug Acetylcholine and appetitive behavior 12 treatment, which followed through into the subsequent training trials. These effects were verified with single effects analyses (utilizing corrected F values) comparing both scopolamine groups with the control group; simple main effects were significant for both low (F 1,19 = 6.59, p < .05) and high dose (F 1,19 = 10.12, p < .01) drug treatments. Treatment X day interactions also achieved significance for both groups (p < .01). The control group and the 1.0 g/side group
showed reliable bar-pressing on day 3, although the rate of subsequent learning increased less rapidly in the low dose group. The rats that received the high dose of the drug did not demonstrate consistent bar-pressing behavior until day 9.
Comparison of lever pressing rates across the final two days of the experiment revealed an interaction effect between days and treatment (F 2,19 = 9.13, p < .01), as well as a significant main effect of treatment day (F 1,19 = 23.82, p < .01). Tukey's HSD statistic was used to compare the number of bar presses between the final training day and the performance test within each treatment group. Although all groups pressed less on the treatment day compared to the previous training day, the decreases in lever pressing were not reliably significant for saline or low-dose scopolamine (p > .05); the high dose scopolamine group demonstrated impaired performance following drug treatment (p < .01).
There was no effect of mecamylamine treatment in the nucleus accumbens core on the learning of the instrumental task (treatment main effect: F 1,15 = 0.06, p > .10; treatment X day interaction: F 9,135 = 0.94, p >.10). Both saline and mecamylamine animals were reliably lever pressing on day 3 of training. Neither was there an effect of mecamylamine treatment on performance (treatment X day interaction: F 1,15 = 0.56, p > .10).
Nucleus accumbens shell. Muscarinic and nicotinic blockade in the nucleus accumbens shell were run together in two separate cohorts of animals, each with a full control group.
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Controls were combined for the final analysis (N control group = 15; 8 rats were in each drug group). Thus, scopolamine treatments in the shell, as in the nucleus accumbens core, impaired instrumental conditioning in a dose-dependent manner. It should be noted that the higher variability and lower asymptotic performance in the low dose scopolamine group was the result of two animals that never learned the task.
A significant interaction of treatment X day was observed on the final two days of testing (F 3,35 = 10.78, p < .001). Tukey HSD comparison of group means between days suggested that both the low (p < .05) and high dose (p < .01) of scopolamine impaired post-training performance, whereas there was no effect of saline or mecamylamine infusion (p > .05).
Unconditioned effects of cholinergic receptor blockade on locomotor and feeding behavior
In order to examine possible non-specific effects of the drug treatments on locomotion and food intake, separate groups of food-deprived animals were subjected to a 15 minute sucrose intake session under the influence of the same drug conditions that were utilized within the instrumental training paradigm. Tables 1 and 2 demonstrate the effect of drug doses on fooddirected and locomotor activity into the core and shell, respectively. All behavioral measures were evaluated by repeated-measures ANOVAs performed across treatments, with significance set at = .05. Post-hoc comparisons of drug treatments versus saline infusions utilized the Tukey HSD. Values of each ANOVA are not reported for purposes of simplicity; all statistically significant differences are denoted in the tables. High dose infusions of scopolamine (but not mecamylamine) into either the nucleus accumbens core or shell decreased feeding behavior and increased locomotor activity. Low dose scopolamine reduced food consumption but did not alter locomotor behavior. Rats showed equal latencies to initiate the first feeding bout in all drug conditions, and scopolamine-treated rats approached the food at least as often as control animals (the only significant change was with high dose scopolamine treatment in the core, which increased approaches to the food). However, total time spent feeding was reduced in the high dose condition in both shell and core, and scopolamine-treated animals consumed less food than the control group in both infusion sites. Mean feeding bout length was significantly decreased in response to high dose scopolamine in the accumbens core (relative to the saline group); there was a trend for a similar decrease in the shell as well (p < .10). Injections of the 10 g scopolamine into the nucleus accumbens core increased the time taken to initiate the first drinking bout, but did not significantly alter the number of drinking bouts or time spent drinking (data not shown).
Repeated-measures ANOVAs on the number of center-crossings and rearing events for
each site also showed a significant effect of treatment in both nucleus accumbens sites. Post-hoc comparisons demonstrated that this effect was due to increases in both of these measures during intra-accumbens infusions of the high dose scopolamine treatment, but not for the low dose.
There was no effect of mecamylamine treatment on any of the locomotor or feeding measures utilized here.
Microanalysis of post-training performance under muscarinic blockade
Given that we observed an increase in locomotor activity in the locomotor and feeding control paradigm, one possible interpretation of these data are that scopolamine grossly impairs the abilities of rats to perform the required behaviors in the chamber. Although those increases in activity were limited to the high dose of the drug in the locomotor paradigm, it is possible that even the low dose of the drug could have resulted in impairments of performance of the intricate movements required to press the lever and retrieve the sucrose pellet in the instrumental condition. To address this issue, we further analyzed the raw data from the instrumental learning experiments (above), and calculated the time between each lever press and nose poke, the time it took the animal to perform a nose poke (presumably in the process of retrieval of the sugar pellet) once a reinforcer had been earned, and the time between each nose poke and its subsequent lever press (see Method for additional details). The median time for each of these three "dyads" was calculated for each animal in the control, low, and high dose scopolamine on the final two days of each experiment. The distributions of these medians were subsequently plotted for the treatment groups in both nucleus accumbens core and shell (Figure 3 ). Very little difference was seen in these median distributions, even in the high dose condition, at a time that the scopolamine-treated rats pressed an average of half as many times within the session.
The effect of nucleus accumbens core scopolamine treatment in the progressive ratio condition
In order to test possible effects of muscarinic receptor blockade on the motivational value of the reinforcer, we trained eight animals in a one-hour progressive ratio paradigm (see Methods). We then examined the effect of increasing doses of nucleus accumbens core scopolamine on the amount of work a rat would maintain to continue receiving sucrose reward.
The results of this experiment are shown in This interpretation is consistent with the overall pattern of observations from these experiments. As lever pressing was reduced following acquisition in response to high-dose scopolamine challenge in both the shell and core (as well as the low dose group in the shell), it is likely that muscarinic blockade mediated neural processes present during both learning and performance of this task. Although acute high dose scopolamine treatment in both nucleus accumbens sites caused increases in locomotion (as measured in the locomotor and feeding experiments), post-training muscarinic blockade did not increase the rats' median latencies between the necessary motor acts required to earn and collect the sucrose reward within the operant chamber (see Figure 3) . Therefore, gross locomotor impairments per se cannot be argued to be the source of performance effects in the high dose group, and are unlikely to explain the learning deficits seen in the low dose scopolamine condition (as 1 g caused no change in locomotion or post-training latencies between behavioral dyads). Additionally, in the locomotor and feeding experiments, sucrose intake was significantly reduced in response to both high and low dose scopolamine treatment in the shell and core. Thus, on the short term, hungry animals reduced their consumption of freely available sucrose pellets while under the influence of nucleus accumbens muscarinic blockade.
Additionally, we directly tested the effects of muscarinic blockade of the nucleus accumbens core upon the amount of work animals would undertake to obtain sucrose, as measured by break point within a progressive ratio paradigm. In contrast to break point increases that we have observed with nucleus accumbens infusions of amphetamine or opiates (M. Zhang, Balmadrid, & Kelley, 2003) , we found a dose-dependent trend for scopolamine to reduce break point. This reduction supports the hypothesis that accumbens muscarinic blockade reduces the reinforcing value of the sucrose. That the trend just missed statistical significance (p = .051) may be the result of the relative level of overtraining the progressive ratio animals received prior to drug treatments, as compared to the instrumental learning condition. It is also possible that the reward-reducing effects of scopolamine would have been more evident had we Acetylcholine and appetitive behavior 18 used a reinforcement schedule that elicited more vigorous responding in the vehicle condition; in this progressive ratio 2 task, rats earned an average of only 16 pellets during vehicle infusion.
In contrast to the effects of muscarinic receptor blockade, 10 g of the nicotinic antagonist mecamylamine did not impair any of the behaviors measured. Although it is possible that a higher dose of mecamylamine might have been effective in reducing learning and/or performance, this dose is high in consideration of the literature; when infused into the ventral tegmentum, 9 g of mecamylamine consistently increases behavioral measures of withdrawal in animals with chronic nicotine exposure (Hildebrand et al., 1999) . Furthermore, the dose chosen has previously been shown to impair spatial working memory when infused in similar amounts and volumes into hippocampus (i.e. Kim & Levin, 1996; Ohno, Yamamoto, & Watanabe, 1993) .
Therefore, despite evidence linking nicotinic receptor activation to cellular plasticity in the slice and dopamine outflow in the striatum (e.g., Partridge et al., 2002; Wonnacott, Kaiser, Mogg, Soliakov, & Jones, 2000; Zhou, Liang, & Dani, 2001) , it is muscarinic receptors that appear to selectively affect instrumental learning and the value of the sucrose reward in these instrumental and feeding tasks.
The data presented here are consistent with multiple other studies that have also suggested a role for accumbens circuitry in motivational processes. For example, manipulations of dopaminergic, opioid, and GABAergic receptors within nucleus accumbens have been shown to modulate feeding and motivation for food reward (MacDonald, Billington, & Levine, 2003; Ragnauth, Znamensky, Moroz, & Bodnar, 2000; Stratford & Kelley, 1997; M. Zhang, Balmadrid, & Kelley, 2003) . Differential concentrations of dopamine and acetylcholine within the nucleus accumbens may mediate, or vary in relation to, satiety-related processing (Helm, Rada, & Hoebel, 2003) . It has been also been repeatedly demonstrated that tonically active neurons (which are believed to be the cholinergic interneurons of striatum) in monkeys respond to motivationally relevant stimuli (Matsumoto et al., 2001; Ravel et al., 2003; Sardo et al., 2000) .
These cells have recently been shown to be capable of changing responses to aversive stimuli when they are subsequently paired with reward presentation. Specifically, as monkeys learned that a sound previously associated with an aversive outcome (i.e. an air puff) came to predict a juice reward, recorded striatal interneurons altered their firing characteristics in a manner consistent with the presentation of a rewarding (rather than aversive) stimulus (Ravel et al., 2003) . The authors argue that tonically active neurons may mediate the motivational significance of learned stimuli. Our data are consistent with such an interpretation.
The present findings are also in line with previous reports of learning impairments caused by cholinergic manipulations in other striatal regions. For instance, behavioral impairments result from dorsal striatal infusions of cholinergic antagonists during acquisition of appetitive lever-pressing and aversive avoidance paradigms (see Prado-Alcala, 1985 for review, also Tikhonravov, Shapovalova, & Dyubkacheva, 1997 ). More recently, medial dorsal striatal injections of scopolamine have been shown to impair rats' flexibility to switch responses when reward is moved on the t-maze (Ragozzino et al., 2002) . Selective lesions of striatal cholinergic neurons in mice impair animals' abilities to perform spatial alternation or learn to associate different tones with the appropriate reward locations on the t-maze (Kitabatake et al., 2003) .
Such lesions did not, however, produce deficits on the Morris water maze, in contextual or cued fear conditioning paradigms, or on the rota-rod motor learning task. Kitabataki and colleagues suggested that striatal cholinergic mechanisms are important for reward-related tasks. The data we present here provides the novel insight that selective inhibition of ventral striatal cholinergic mechanisms is sufficient to alter reward-related learning and performance, and that this effect is likely the result of reinforcer devaluation.
We have previously shown that dopaminergic or glutamatergic antagonism within the accumbens core selectively impairs instrumental learning Smith-Roe & Kelley, 2000) . Also, low doses of dopaminergic and glutamatergic antagonists, that do not produce a deficit when injected alone, block learning when infused together (Smith-Roe & Kelley, 2000) . Interestingly, unlike the feeding effects seen as the result of muscarinic receptor blockade, dopaminergic and glutamatergic receptor antagonism (with SCH-22390, AP-5, or both) did not alter either overall food intake or time spent feeding when tested in a similar locomotor and feeding paradigm to the one used here (Baldo, Sadeghian, Basso, & Kelley, 2002; Kelley et al., 1997; Smith-Roe & Kelley, 2000) . This suggests that nucleus accumbens cholinergic receptors play a unique, if complementary role, in accumbens-based neural processing.
The nucleus accumbens has long been argued to provide a means for limbic information to interface with motor processes (Mogenson, Jones, & Yim, 1980) . Environmental contextual information, which presumably arrives from cortical limbic inputs into the nucleus accumbens, may come to elicit behavioral repertoires based on the reinforcement history of the context (Mizumori, Pratt, & Ragozzino, 1999) . Dopaminergic signals filter glutamatergic signals from limbic cortex (e.g., O'Donnell, 2003; Yang & Mogenson, 1984; Yim & Mogenson, 1982) , and may provide a means for predictive reward information (e.g., Schultz, 1998) to affect ongoing neural activation patterns in the accumbens. The distribution of cholinergic receptors within the striatum suggests multiple roles for acetylcholine in presynaptically mediating accumbens glutamate and dopamine outflow (e.g. Contant, Umbriaco, Garcia, Watkins, & Descarries, 1996; Hersch, Gutekunst, Rees, Heilman, & Levey, 1994; Izzo & Bolam, 1988) (Beninger & Ranaldi, 1993; Smith-Roe & Kelley, 2000) .
Postsynaptically, M1 receptor activation decreases current through NMDA channels on medium spiny neurons, and muscarinic receptor antagonism (particularly of the M1 subtype) reduces plasticity within the striatal slice preparation Calabresi et al., 1998) . Our data do not preclude the possibility that blockade of these receptors in vivo may have directly impaired plasticity during the acquisition phase of this experiment. M2 receptors are found chiefly on the cholinergic interneurons themselves, and have been argued to autoregulate cholinergic output (Hersch et al., 1994 , but see W. Zhang, Yamada, Gomeza, Basile & Wess, 2002 . Less is known about the physiological role of the remaining muscarinic receptor subtypes in the modulation of striatal transmitters and plasticity, although recent evidence suggests that M3 and M5 receptors also mediate dopaminergic actions Acetylcholine and appetitive behavior 22 within striatum (W. Zhang et al., 2002) . Future studies will delineate the effects of specific acetylcholine receptor blockade within the experimental paradigms utilized here.
Given the known interactions between acetylcholine and other striatal components, it is surprising that there has not been more research into the role of nucleus accumbens acetylcholine in mediating learning and behavior. Recent experiments have made it clear that both cortical and striatal acetylcholine serves an important role in learning and memory processes. Relative levels of cholinergic activation between regions may serve as an important indicator of task involvement, as it has been recently argued that cholinergic levels in hippocampus and dorsal striatum reflect strategies selected by rats on the T-maze (Chang & Gold, 2003; McIntyre, Marriott, & Gold, 2003) . However, much of the cortex receives cholinergic innervation from the basal forebrain regions, whereas the striatum's cholinergic influence arises predominantly from its own interneurons. Understanding the influence of these neurons in striatal function is imperative to the understanding of basal ganglia functions involved in cognitive as well as movement processes. The experiments reported here suggest that muscarinic acetylcholine receptors within the nucleus accumbens shell and core are important for plasticity underlying appetitive instrumental learning, most likely by modulating the motivational value of the reinforcer. nicotinic antagonism by 10 g mecamylamine was without effect. Lever pressing also decreased after learning in response to high dose scopolamine treatment in the core, as well as both high and low dose treatments in the shell. Numbers in parentheses () denote animals included in each group; the control group for both shell treatments consisted of the same 15 animals. * p < .05, treatment effect, ** p < .01, treatment effect, ‡, p < .01, interaction of treatment x day. time animals take to complete these behavioral dyads, suggesting that the decreases in responding on the final experimental day was not the result of gross impairments in the animals' abilities to perform the task. Figure 4 . Effects of nucleus accumbens core muscarinic blockade on break point and lever pressing within the progressive ratio paradigm. Increasing doses of scopolamine show a trend toward decreasing break point and total lever presses for the session. Post-hoc contrasts showed
